(Hypertension. 1996;27:564-568.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Physiology, Medical College of Wisconsin, Milwaukee (D.E.S., R.J.R.), and Department of Physiology, Medical College of Ohio, Toledo (A.Y.D., J.P.R.).
| Abstract |
|---|
|
|
|---|
Key Words: hydroxyeicosatetraenoic acid cytochrome P-4504A2 gene expression NaCl, dietary rats, Dahl
| Introduction |
|---|
|
|
|---|
To determine whether alterations in the renal metabolism of AA by P450 enzymes contribute to the development of hypertension, a genetic linkage analysis for the alleles at the P4504A2 enzyme was performed in an F2 generation of a cross between SS/Jr and Lewis rats. We also evaluated whether there are phenotypic differences in the expression of the P4504A2 protein and enzyme activity in the kidneys of the parental strains used in the cross.
| Methods |
|---|
|
|
|---|
The cosegregation analysis was performed on 151 male F2 rats derived from a cross of SS/Jr rats with Lewis rats and designated as F2 (SxLew). The rats were weaned 3 weeks after birth and placed on a high salt (8% NaCl) diet (TD82050, Teklad) for the duration of the experiment. Systolic blood pressure was measured at weekly intervals in the population by the tail-cuff microphonic manometer method in conscious, restrained rats. When blood pressures of some of the rats reached 200 mm Hg, the blood pressures of all the rats in the population were measured over a 7- to 10-day period. A daily measurement of pressure was taken as the average of three consistent blood pressure measurements. The blood pressure of each rat was measured on three separate days, and the average pressure recorded over the 3-day period was the blood pressure for that rat.
Genotyping
DNA was extracted from the livers of the rats
according to the
method of Blin and Stafford.13 The rats were
genotyped by PCR as previously described14 at the
P4504A2 locus with PCR primers designed around a tandem-repeated
element in intron 11 of the P4504A2 gene obtained from a
published sequence.15 The sequences of the primers used
were as follows: forward, 5'-TGGCACTGTCCAAATGA-3'; reverse,
5'-GCTTAGGCTCCTGACCT-3'. The linkage analysis for P4504A2 was
completed using other markers on rat chromosome 5 as previously
described by Deng et al.16
Renal Metabolism of AA and P4504A Expression
Studies
These experiments were performed on 12-week-old male Lewis
rats purchased from Charles River Laboratories and Dahl SS/Jr obtained
from a colony of rats maintained at the Medical College of Wisconsin.
This colony was originally derived from SS/Jr rats purchased from
Harlan Industries in 1991, before any evidence of genetic contamination
of this strain.17 The rats have since been maintained by
brother-sister mating in a closed breeding colony for 16 additional
generations. The rats in this colony all develop severe hypertension
when placed on a high salt diet for 3 weeks (with mean
arterial pressures >170 mm Hg); the littermates of the
rats used in this study (n=8) were extensively genotyped with
40 markers (2 or 3 per chromosome), and no evidence of genetic
contamination could be detected (R.S.R., 1995, unpublished
observation).
Preparation of Renal Microsomes
Experiments were performed on
male SS/Jr and Lewis rats
maintained on a normal salt diet (1% NaCl by weight). The rats were
anesthetized with pentobarbital (30 mg/kg IP), and the kidneys
were rapidly removed, hemisected, sectioned into cortex and outer
medulla, and placed into an ice-cold
homogenization buffer. The tissue was
homogenized in 3 mL potassium phosphate
homogenization buffer (10 mmol/L, pH 7.7)
containing (in mmol/L) sucrose 250, EDTA 1, and PMSF 0.1. The
homogenate was centrifuged at 3000g for
15 minutes to remove large pieces of tissue, and the supernatant was
centrifuged at 9000g for 15 minutes, followed by
100 000g for 1 hour. The microsomal pellet was resuspended
in a potassium phosphate buffer (100 mmol/L, pH 7.2) that contained
30% glycerol, 1 mmol/L dithiothreitol, 1 mmol/L EDTA, and 0.1 mmol/L
PMSF and was stored at -80°C until P450 activity was
determined.
Renal Metabolism of AA
Renal P4504A enzyme activity was
measured by incubating
microsomes prepared from the renal cortex and outer medulla of the rats
(0.5 mg protein) with [14C]AA (0.1 µCi/mL, 20
µmol/L)
in 1 mL of a potassium phosphate buffer (pH 7.4) containing (in mmol/L)
MgCl2 5, EDTA 1, and NADPH 1 and an NADPH-regenerating
system (10 mmol/L isocitric acid and isocitrate dehydrogenase 0.4 U/mL,
Sigma). Samples were incubated at 37°C for 30 minutes after the
addition of NADPH. The reactions were terminated by acidification to pH
4.0 with 0.1 mol/L formic acid, the samples were extracted twice with
ethyl acetate and dried under N2 gas, and the residue was
resuspended in 500 µL of 100% ethanol. The metabolites were
separated by use of a Hitachi 655A-1 high-performance
liquid chromatography gradient system equipped with a
C18 reverse-phase column (2.1x250 mm, 5 µm; Supleco) and a 2-cm
guard column (Supleco). A linear elution gradient ranging from
acetonitrile/water/acetic acid (50:50:2 vol/vol/vol) to
acetonitrile/acetic acid (100:0.2, vol/vol) was used. The rate of
change was 1.25% per minute at a flow rate of 0.5 mL/min. Metabolites
were monitored by a radioactive flow detector (Flo-oneBeta,
series A-120, Radiomatic Instruments) specially modified with lead
shielding for a low background. The mean production rate for
each metabolite was calculated and expressed as picomoles formed per
minute per micrograms of protein.
Immunoblots
Microsomal protein prepared from the renal cortex
(15
µg) and outer medulla (50 µg) of the Dahl S and Lewis-Wistar rats
was separated by electrophoresis on a 7.5% sodium dodecyl
sulfate gel (15x15 cm) for 14 hours at 80 V. Proteins were transferred
electrophoretically to a nitrocellulose membrane (Trans-Blot, Bio-Rad)
at 40 V in a buffer consisting of 25 mmol/L Tris-HCl, 192 mmol/L
glycine, and 20% methanol for 4 hours at 4°C. The membrane was
blocked for 2 hours by immersion in a buffer (TBST-20) containing 10
mmol/L Tris-HCl, 150 mmol/L NaCl, 0.8% Tween-20, and 5% nonfat dry
milk and incubated with a 1:2000 dilution of a polyclonal antibody
raised against a 20-mer synthetic peptide in the rat P4504A1 sequence
that recognizes all three of the 4A isoforms.18 The
membrane was washed in TBST-20 buffer and incubated for 1 hour with a
1:1000 dilution of an alkaline phosphatasecoupled goat
anti-rabbit second antibody (Zymed). The membrane was then placed
in a color development solution (Bio-Rad), and the relative intensities
of the bands in the 50- to 52-kD range were quantified with a
densitometer (Personal Densitometer SI, Molecular Dynamics).
Statistics
Mean±SEM values are presented. The
significance of
differences in mean values was evaluated with either a paired or an
unpaired t test. A value of P<.05 was considered
to be statistically significant. QTLs were identified with the MAPMAKER
program.19
| Results |
|---|
|
|
|---|
|
Expression of P4504A Protein in the Kidney
Western blot
experiments were performed with an antibody raised
against a synthetic peptide sequence in rat P4504A1 protein that
recognizes all three 4A isoforms in the liver and kidney of
rats.18 The purpose of these experiments was to determine
whether the differences observed in enzyme activity in SS/Jr and Lewis
rats were associated with changes in the levels of P4504A protein in
the kidneys of these rats. The results of these experiments are
presented in Fig 2
. The P4504A2 enzyme was the
only isoform detected in microsomes prepared from either the renal
cortex or outer medulla of male SS/Jr and Lewis rats. The levels of 4A2
protein were threefold higher in the renal cortex of Lewis than in
SS/Jr rats. In the outer medulla, the levels of 4A2 protein were also
threefold greater in Lewis rats compared with the levels in SS/Jr rats
(Fig 2B
).
|
Cosegregation Analysis
The F2 (SxLew)
population was genotyped for
the P4504A2 locus. The P4504A2 locus mapped to a region on rat
chromosome 5, 3.3 cM (centiMorgans) from a glucose transporter locus
and 2.6 cM away from the endothelin 2 locus. Both of these loci have
previously been reported to cosegregate with blood pressure in this
cross.16 The results of the present cosegregation
analysis are presented in Fig 3
. The
P4504A genotype cosegregated with systolic blood
pressure (P<.0001), and the effect of the P450
genotype on systolic pressure was quite large, with
average pressures of 201±6 mm Hg in the rats with an SS
genotype (n=36), 192±4 mm Hg in heterozygote rats with an SL
genotype (n=77), and 169±3 mm Hg in rats with the LL
genotype (n=38).
|
| Discussion |
|---|
|
|
|---|
In the present study, we compared the renal metabolism of AA by P450 and the expression of the P4504A proteins in the kidneys of the parental strains. Despite significantly higher levels of P4504A2 protein in the cortex of Lewis rats compared with SS/Jr rats, no significant differences were observed in the cortical production of 20-HETE between SS/Jr and Lewis rats. The reason why 20-HETE is not elevated in the renal cortex despite an elevation in P4504A2 protein is unknown. One possibility is that there may be differences in levels of other cofactors such as cytochrome P450 reductase and B5 in the renal cortex in Lewis rats that compensate for the difference in 4A2 protein. It is also possible that some of the immunoreactive P4504A2 protein detected in the cortex of Lewis rats may be inactive. Clearly, further investigation will be required to examine the reasons behind this observation.
The production of 20-HETE was reduced in the outer medulla of the kidney of SS/Jr rats in comparison with the levels seen in Lewis rats, and this was associated with threefold lower levels of the P4504A2 protein in the outer medulla of SS/Jr rats compared with Lewis rats. These results establish that there is a marked difference in the production of 20-HETE in the appropriate region of the kidney between the parental strains of the rats used to generate the F2 population for the cosegregation studies. Moreover, we have confirmed in micropuncture studies that the P4504A system directly influences Cl- transport in the TALH20 and that an abnormality in this system appears to contribute to the elevation in Cl- transport seen in SS/Jr rats. In these experiments, addition of an inhibitor of the production of 20-HETE to fluid perfusing the loop of Henle of SR/Jr rats increased Cl- transport to the same level as that observed in SS/Jr rats, and it had no effect on loop Cl- transport in SS/Jr rats. Similarly, addition of the putative mediator, 20-HETE, to the perfusate normalized loop Cl- transport in SS/Jr rats, but it had much less effect in Dahl R rats, in which the endogenous levels of this compound are higher. These biochemical and functional results are also consistent with our previous observation that induction of the renal production of 20-HETE can prevent the development of hypertension in SS/Jr rats fed a high salt diet.12
In summary, the present findings indicate that the renal metabolism of AA by P450 and the steady state levels of the P4504A2 protein in the outer medulla of the kidney are lower in SS/Jr than in Lewis rats and that the P4504A genotype cosegregates with blood pressure in an F2 cross derived from these strains. The product of this enzyme, 20-HETE, serves as an endogenously formed inhibitor of Cl- transport in the TALH of SS/Jr rats.9 10 This system appears to be a viable candidate gene that may contribute to the elevation in loop Cl- transport,5 6 7 8 the resetting of the pressure-natriuresis relation,3 and the development of hypertension in SS/Jr rats.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. L. Mattson, M. R. Dwinell, A. S. Greene, A. E. Kwitek, R. J. Roman, H. J. Jacob, and A. W. Cowley Jr. Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease Am J Physiol Renal Physiol, September 1, 2008; 295(3): F837 - F842. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Laffer, J. V. Gainer, M. R. Waterman, J. H. Capdevila, M. Laniado-Schwartzman, A. Nasjletti, N. J. Brown, and F. Elijovich The T8590C Polymorphism of CYP4A11 and 20-Hydroxyeicosatetraenoic Acid in Essential Hypertension Hypertension, March 1, 2008; 51(3): 767 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Stec, R. J. Roman, A. Flasch, and M. J. Rieder Functional polymorphism in human CYP4F2 decreases 20-HETE production Physiol Genomics, June 19, 2007; 30(1): 74 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman, K. M. Hoagland, B. Lopez, A. E. Kwitek, M. R. Garrett, J. P. Rapp, J. Lazar, H. J. Jacob, and A. Sarkis Characterization of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1463 - F1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vera, M. Taylor, Q. Bohman, A. Flasch, R. J. Roman, and D. E. Stec Fenofibrate Prevents the Development of Angiotensin II-Dependent Hypertension in Mice Hypertension, April 1, 2005; 45(4): 730 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Hoagland, A. K. Flasch, A. J. Dahly-Vernon, E. A. dos Santos, M. A. Knepper, and R. J. Roman Elevated BSC-1 and ROMK Expression in Dahl Salt-Sensitive Rat Kidneys Hypertension, April 1, 2004; 43(4): 860 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ma, J. Graves, J. A. Bradbury, Y. Zhao, D. L. Swope, L. King, W. Qu, J. Clark, P. Myers, V. Walker, et al. Regulation of Mouse Renal CYP2J5 Expression by Sex Hormones Mol. Pharmacol., March 1, 2004; 65(3): 730 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xu, J. R. Falck, P. R. Ortiz de Montellano, and D. L. Kroetz Catalytic Activity and Isoform-Specific Inhibition of Rat Cytochrome P450 4F Enzymes J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Laffer, M. Laniado-Schwartzman, A. Nasjletti, and F. Elijovich 20-HETE and Circulating Insulin in Essential Hypertension With Obesity Hypertension, February 1, 2004; 43(2): 388 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Laffer, M. Laniado-Schwartzman, M.-H. Wang, A. Nasjletti, and F. Elijovich Differential Regulation of Natriuresis by 20-Hydroxyeicosatetraenoic Acid in Human Salt-Sensitive Versus Salt-Resistant Hypertension Circulation, February 4, 2003; 107(4): 574 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Stec, A. Flasch, R. J. Roman, and J. A. White Distribution of cytochrome P-450 4A and 4F isoforms along the nephron in mice Am J Physiol Renal Physiol, January 1, 2003; 284(1): F95 - F102. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Intrarenal Transport and Vasoactive Substances in Hypertension Hypertension, September 1, 2001; 38(3): 621 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Capdevila, J. R. Falck, and R. C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res., February 1, 2000; 41(2): 163 - 181. [Abstract] [Full Text] |
||||
![]() |
J. P. Rapp Genetic Analysis of Inherited Hypertension in the Rat Physiol Rev, January 1, 2000; 80(1): 135 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ma, W. Qu, P. E. Scarborough, K. B. Tomer, C. R. Moomaw, R. Maronpot, L. S. Davis, M. D. Breyer, and D. C. Zeldin Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney J. Biol. Chem., June 18, 1999; 274(25): 17777 - 17788. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Nguyen, M.-H. Wang, K. M. Reddy, J. R. Falck, and M. L. Schwartzman Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1691 - R1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ito and R. J. Roman Regulation of P-450 4A activity in the glomerulus of the rat Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1749 - R1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Orlov, N. C. Adragna, V. A. Adarichev, and P. Hamet Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension Am J Physiol Cell Physiol, March 1, 1999; 276(3): C511 - C536. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ito and R. J. Roman Role of 20-HETE in Elevating Chloride Transport in the Thick Ascending Limb of Dahl SS/Jr Rats Hypertension, January 1, 1999; 33(1): 419 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Husted, J. P. Rapp, and J. B. Stokes Candidate Genes in the Regulation of Na+ Transport by Inner Medullary Collecting Duct Cells From Dahl Rats Hypertension, February 1, 1998; 31(2): 608 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Stec, D. L. Mattson, and R. J. Roman Inhibition of Renal Outer Medullary 20-HETE Production Produces Hypertension in Lewis Rats Hypertension, January 1, 1997; 29(1): 315 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-P. Zou, H. A. Drummond, and R. J. Roman Role of 20-HETE in Elevating Loop Chloride Reabsorption in Dahl SS/Jr Rats Hypertension, March 1, 1996; 27(3): 631 - 635. [Abstract] [Full Text] |
||||
![]() |
M. R. Garrett and J. P. Rapp Two closely linked interactive blood pressure QTL on rat chromosome 5 defined using congenic Dahl rats Physiol Genomics, February 28, 2002; 8(2): 81 - 86. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |